The best Side of "3
Other medical trials in clients with non-Hodgkin's lymphoma [24] and clients with Highly developed malignancy [fourteen] have demonstrated also that zosuquidar did not noticeably impact the pharmacokinetics of doxorubicin and had average outcomes about the pharmacokinetics of vincristine. These medical trials authorized that zosuquidar could secure